Summit Therapeutics Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 01/20/2023   Download
SEC Document
SEC Filing
On January 19, 2023, Summit filed Amendment No. 2 to the Restated Certificate of Incorporation (the “Amendment No. 2”) with the Secretary of State of the State of Delaware to increase the number of authorized shares of our common stock by 650,000,000 (from 350,000,000 to 1,000,000,000), which became effective on such date.